Table 4.
The impact of thrombolytic therapy upon outcome after acute myocardial infarction. Data from 58,600 patients randomized into nine trials of 1,000 or more patients where thrombolysis was administered within 24 h. Day 0 was the day of randomization. Major bleeding includes non-cerebral bleeding that required blood transfusion or was life-threatening. Data derived from the Fibrinolytic Therapy Trialists’ Collaborative Group [13].